NDC 0173-0898 – Jemperli
Dostarlimab 50 mg/mL · Injection · Intravenous
Product NDC0173-0898
Product details
- Brand name
- Jemperli
- Generic name
- Dostarlimab
- Labeler
- GlaxoSmithKline LLC
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761174
- Marketed since
- April 22, 2021
- Listing expires
- December 31, 2027
- Pharmacologic class
- Programmed Death Receptor-1 Blocking Antibody
Active ingredients
- Dostarlimab 50 mg/mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 0173-0898-03 | 1 VIAL in 1 CARTON (0173-0898-03) / 10 mL in 1 VIAL | Apr 22, 2021 |